Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 11.
United-Guardian Reports 20% Earnings Increase
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HAUPPAUGE, N.Y., Nov. 12, 2009 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (Nasdaq:UG) reported today that earnings reached a record level for the first nine months of 2009, increasing 20% over last year to $2,992,420 ($0.60 per share) from $2,487,057 ($0.50 per share) in the same period in 2008. Earnings for the 3 months ended September 30, 2009 increased 22% to $1,081,748 ($0.22 per share) from $911,494 ($0.18 per share) in the third quarter of 2008. Net sales for the 9-month period were up 8% compared with last year, primarily due to an increase in sales of the company's medical lubricant products, which increased by 41%....
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
SGR Repair Bill Failure Could Cool Physician Support for Healthcare ReformEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Organized medicine is anticipating a vote on a bill that would rewrite Medicare's controversial sustainable growth rate formula for physician reimbursement, which would avert a 21.2% pay cut for 2010. Medscape Medical News
Source: Medscape Business of Medicine Headlines - November 12, 2009 Category: Pharmaceuticals Source Type: info
The Female Health Company's Second Generation Product, FC2, is Issued Patent for EuropeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHICAGO, Nov. 12, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO), today reported that a patent has been issued on its second generation product, FC2, by the European patent office. In addition to Europe, FC2 patents have been issued in Canada, Australia, the Republic of South Africa and the People's Republic of China. FC2 patent applications are pending in the U.S., Japan and various other countries.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Mersana Therapeutics Publishes Review Article Detailing Advantages of its Lead Cancer Compound in Journal of Advanced Drug Delivery ReviewsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Fleximer(R) Conjugate XMT-1001 Demonstrates
Prolonged Stable Disease Without Severe Side Effects Associated
with Camptothecin or Irinotecan -
CAMBRIDGE, Mass., Nov. 12 /PRNewswire/ -- Mersana Therapeutics,
a platform-based cancer therapeutics...
Source: Drugs.com - Clinical Trials - November 12, 2009 Category: Pharmaceuticals Source Type: clinical trials
Results From Chelsea Therapeutics' Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 20th Annual International Symposium on the Autonomic Nervous SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHARLOTTE, N.C., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that Horacio Kaufmann, M.D. will present results from Droxidopa Study 302 at the American Autonomic Society's 20th Annual International Symposium on the Autonomic Nervous System in St. Thomas, U.S. Virgin Islands. Preliminary results from Study 302, the first of two pivotal Phase III trials in Chelsea's registration program of Droxidopa for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH), were first reported on September 24, 2009.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Ross Stocks Dual Shaft MixersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Charles Ross and Son Company today announced the in-stock availability several sizes of its Dual Shaft Change Can Mixers.
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Trading Outlook for StemCells Inc. Issued by InvestorSoup.comEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DALLAS, Nov. 12, 2009 (GLOBE NEWSWIRE) -- InvestorSoup.com announces an investment report featuring StemCells Inc. (Nasdaq:STEM). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news
Ranbaxy gets WHO approval for AIDS drugEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Ranbaxy Laboratories , India's top drug maker by sales, said on Thursday that it has received the World Health Organization pre-qualification for its Indinavir anti-retroviral AIDS drug.
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Pioneering New Methods Of Drug ManufactureEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Engineers at the University of Leeds have developed a simple technology which can be used in existing chemical reactors to ensure "right first time" drug crystal formation. Ensuring drug crystals are formed correctly is crucial to their efficacy and the efficiency of pharmaceutical manufacturers' operations.
Source: Pharma Industry News From Medical News Today - November 12, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
Viron To Present Data From Phase II Trial At American Heart Association ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Viron Therapeutics Inc., a biopharmaceutical company pioneering the development of viral protein therapeutics, announced that the Company's research collaborator, Dr. Jean-Claude Tardif, Director of the Research Center at the Montreal Heart Institute, will present data from a Phase IIa clinical trial evaluating VT-111 at the American Heart Association (AHA) Scientific Sessions 2009 conference. The conference will take place in Orlando, Florida from November 14 to 18, 2009.
Source: Pharma Industry News From Medical News Today - November 12, 2009 Category: Pharmaceuticals Tags: Heart Disease Source Type: news
Pandemic 2009 Influenza Update: Pandemrix™ Data On Co Administration With Annual Seasonal Influenza Vaccine (Fluarix®)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline (GSK) announced the results from the clinical trial assessing Pandemrix™, GSK's adjuvanted H1N1 pandemic influenza vaccine, administered at the same time as the annual seasonal influenza vaccine, Fluarix ®. The trial showed that co-administration of one dose of both vaccines in separate arms, induced a strong response in adults for both the H1N1 pandemic vaccine as well as the seasonal vaccine.
Source: Pharma Industry News From Medical News Today - November 12, 2009 Category: Pharmaceuticals Tags: Swine Flu Source Type: news
Aurobindo gets USFDA approval for hypertension treating drugEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drug firm Aurobindo Pharma on Thursday said that it has received final approval from the US health regulator for Perindopril Erbumine Tablets, used for the treatment of hypertension.
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news
INTERPHEX Aligns Management Team To Enhance Customer Value And ExperienceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INTERPHEX, North America's largest event for the biopharmaceutical manufacturing industry, has aligned its management team to focus its efforts on the customer experience by strengthening key alliances to identify and cultivate new visitor growth. These efforts are being undertaken to embrace the changing needs of the Pharma and biotech marketplace while delivering customer value and engagement thus fortifying the INTERPHEX brand.
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Teva Receives Final Approval For Generic Prevacid(R) Delayed-Release CapsulesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Tap Pharmaceutical's proton pump inhibitor Prevacid® (lansoprazole) Delayed-Release Capsules, 15 mg and 30 mg. Customers will begin receiving product on November 11, 2009. Annual sales of Prevacid® Delayed-Release Capsules were approximately $2.
Source: Pharma Industry News From Medical News Today - November 12, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
Abbott to Acquire Novel Investigational Biologic to Treat Chronic PainEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: Abbott.com - November 12, 2009 Category: Pharmaceuticals Source Type: organizations
New Web Sites Educate About Triglycerides and HDL CholesterolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New Web sites Educate about Triglycerides and HDL Cholesterol
Source: Abbott.com - November 12, 2009 Category: Pharmaceuticals Source Type: organizations
Health-Bill Battle Won't Get a RecessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Groups on all sides of the health-care debate are using Congress's recess to put pressure on lawmakers.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
FDA, Pharma Meet on Web PostsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Unions Battle Over Health WorkersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As labor leaders fight to sign up 10,000 health-care workers, a California-based union is charging the SEIU with changing ballots and threatening to report a worker to immigration officials.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Endo Pharmaceuticals And LecTec Settle Patent DisputeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510.
Source: Pharmaceutical Online News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Generic-Drug Makers Protest Supply LimitsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FTC expressed concern about the practices of brand-name drug makers after generic drug companies complained they can't get bulk supplies of some medicines they want to copy.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Health-Bill Battle Won't Get a RecessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Groups on all sides of the health-care debate are using Congress's recess to put pressure on lawmakers.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Watch out for US recovery, new productsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Robust growth in profits despite modest rise in revenues characterised the performance of the Indian pharma sector for the latest quarter ended September 2009.
Source: The Economic Times Healthcare and Biotech News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Health Bill Battle Gets No RecessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Groups on all sides of the health-care debate are using Congress's recess to put pressure on lawmakers.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Generic-Drug Makers Protest Supply LimitsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The FTC expressed concern about the practices of brand-name drug makers after generic drug companies complained they can't get bulk supplies of some medicines they want to copy.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
FDA, Pharma Meet on Web PostsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As federal regulators take their first tentative steps toward policing the wild west of medical information online, pharmaceutical companies are pressing their case to market drugs via Google, Twitter and other Web sites.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Unions Battle Over Health WorkersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As labor leaders fight to sign up 10,000 health-care workers, a California-based union is charging the SEIU with changing ballots and threatening to report a worker to immigration officials.
Source: WSJ.com: Health - November 12, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Ratiopharm offers emergeEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Four financial investors, along with Israel's Teva, France's Sanofi-Aventis and the US's Pfizer, have submitted bids for the world's fourth-largest generic drugs group
Source: FT.com - Drugs and Healthcare - November 12, 2009 Category: Pharmaceuticals Source Type: news
FDA approves GSK's pandemic H1N1 vaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has approved a supplemental biologics license application (sBLA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.
Source: World Pharma News - November 12, 2009 Category: Pharmaceuticals Source Type: news
FDA Commissioner Addresses Nation's Healthcare Professionals on H1N1 VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr. Margaret Hamburg, Commissioner of Food and Drugs, sent a letter to America's healthcare professionals thanking them for their efforts during the 2009 H1N1 influenza outbreak and providing information on the safety of the 2009 H1N1 vaccines.
Source: World Pharma News - November 12, 2009 Category: Pharmaceuticals Source Type: news
Amgen to Present at 18th Annual Credit Suisse Healthcare ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
THOUSAND OAKS, Calif., Nov. 12 /PRNewswire-FirstCall/—Amgen (Nasdaq: AMGN) will participate in the 18th Annual Credit Suisse Healthcare Conference on Thursday, Nov. 12, 2009, at the Biltmore Hotel in Phoenix, Ariz., beginning at 9:30 a.m. Mountain Time. Robert A. Bradway, executive vice president and chief financial officer at Amgen, will present at the conference. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, www.amgen.com, under Investors.
Source: Amgen News Service - November 12, 2009 Category: Pharmaceuticals Authors: pmannle at amgen.com Tags: Press Releases Source Type: organizations
Powerful Speaking The Obama WayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Three tips for delivering a message effectively like the President.
Source: Forbes.com Healthcare News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Covidien Introduces First FDA-Approved Spine SealantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Fast-acting DuraSeal(TM) spine sealant provides critical watertight seal during spine surgery
NORTH HAVEN, Conn., Nov 11--(HSMN NewsFeed)--Covidien (NYSE: COV ), a leading global provider of healthcare products, today announced the launch of DuraSeal(TM... Devices, Orthopaedic, Neurosurgery, FDACovidien, DuraSeal, spine sealant, spine surgery
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
Cardiac Science Appoints Peter Kingma Senior Vice President Sales and MarketingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOTHELL, Wash., Nov. 11 (HSMN NewsFeed) -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, appointed Peter Kingma as senior vice president, effective immedi... Devices, Cardiology, PersonnelCardiac Science, automated external defibrillator
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
Altair Therapeutics Secures $17 Million FinancingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Round to fund phase 2a clinical trials for lead candidate AIR645, advance R&D
SAN DIEGO, Nov 11--(HSMN NewsFeed)--Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announ... Biopharmaceuticals, Venture CapitalAltair Therapeutics
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
The Copenhagen Master PlanEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Denmark readies for 15,000 to descend for the climate change conference.
Source: Forbes.com Healthcare News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Landmark Study in The Lancet Oncology Shows Capecitabine (Xeloda) Combination Therapy Reduces Early Breast Cancer RecurrenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
- This is a third party press release. It will be issued by the
Finnish Breast Cancer Group on Wednesday 11 November 2009.
- FinXX, a Large, Phase III Randomised Study in Women With Early
Breast Cancer Shows that Adding Capecitabine...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
Health Sciences Group Pursuing Medical MarijuanaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
INDIAN HARBOUR BEACH, Fla., Nov. 11, 2009 (GLOBE NEWSWIRE) -- Health Sciences Group, Inc. (Pink Sheets:HESG) would like to announce that in addition to finalizing a consulting agreement with Medical Marijuana, Inc. in its pursuit to enter the Medical Marijuana business it has also contacted several law firms in California and Colorado for purposes of licensing requirements for dispensaries.
Source: Medical News (via PRIMEZONE) - November 11, 2009 Category: Pharmaceuticals Source Type: news
FTC Says It's Concerned by Drug Makers' PracticesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Federal Trade Commission expressed concern about the practices of brand-name drug makers after generic drug companies complained they can't get bulk supplies of some medicines they want to copy.
Source: WSJ.com: Health - November 11, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Viron to Present Data from Phase II Trial at American Heart Association ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LONDON, ON, Nov. 11 /PRNewswire/ -- Viron Therapeutics Inc., a
biopharmaceutical company pioneering the development of viral
protein therapeutics, announced today that the Company's research
collaborator, Dr. Jean-Claude Tardif, Director of the...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
Video: Sanofi Pasteur Announces Final Results of U.S. Clinical Trials of Influenza A (H1N1) Vaccine in Adults and ChildrenEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Final data confirm immunogenicity, safety profile
- - Single dose provides robust immune response in adults; two
doses provide robust immune response in children 6 months through 9
years -
SWIFTWATER, Pa., Nov. 11 /PRNewswire/ -- Sanofi...
Source: Drugs.com - Clinical Trials - November 11, 2009 Category: Pharmaceuticals Source Type: clinical trials
CLB to hear Ranbaxy plea on FridayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Company Law Board (CLB) will hear a complaint by Ranbaxy Laboratories, which is contesting the appointment of two independent directors on the board of Zenotech by the founder and MD of the Hyderabad-based firm Jayaram Chigurupati, on Friday.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
HC admits DBS’ plea against WockhardtEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Bombay High Court has admitted an application filed by Singapore-based DBS against debt-ridden drug maker Wockhardt’s plans to divest some of its assets.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
Novartis puts R&D activities in India on holdEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MUMBAI: Frustrated with patent challenges, Swiss-pharma giant Novartis has put its research and development (R&D) activities in India on the back burner, its CEO Daniel Vasella said. Mr Vasella, who was in town to attend the Pepsico board meet, said the intellectual property (IP) protection was not up to the mark in India.
Source: The Economic Times Healthcare and Biotech News - November 11, 2009 Category: Pharmaceuticals Source Type: news
EMERGING LEADERS: Elizabeth MutisyaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Elizabeth Mutisya, VP, US Medical Affairs, CMO, Solvay Pharmaceuticals
Source: Pharm Exec Podcast Interviews - November 11, 2009 Category: Pharmaceuticals Authors: Pharmaceutical Executive Source Type: podcasts
Cellerix Raises EUR27 Million in a First ClosingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MADRID, November 11 (HSMN NewsFeed) -- Cellerix, a product-focused biopharmaceutical company which develops innovative medicines based on cell therapy, today announced the successful first closing of its financing round, raising EUR27 million. Participan... Regenerative Medicine, Biopharmaceuticals, Venture CapitalCellerix, Ontaril
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
El Camino Hospital Expands Robotic Surgery ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Latest robotic surgery equipment includes a new system at El Camino Hospital Los Gatos
MOUNTAIN VIEW, Calif., Nov. 11 (HSMN NewsFeed) -- El Camino Hospital, the hospital of Silicon Valley, expands its minimally invasive surgical program to three da Vi... Devices, SurgeryIntuitive Surgical, da Vinci, robotic surgery, El Camino Hospital
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
Texas Children's Hospital Achieves Pediatric Cardiology "First," Discharges Teen with Mechanical Heart Assist DeviceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Teen enjoys normal activities outside of hospital while awaiting donor heart
HOUSTON--(HSMN NewsFeed)--Texas Childrens Hospital is the nations first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a ... Devices, CardiologyThoratec, HeartMate, ventricular assist device
Source: HSMN NewsFeed - November 11, 2009 Category: Pharmaceuticals Source Type: news
